12:00 AM
Apr 15, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Diclegis doxylamine/pyridoxine regulatory update

FDA approved Diclegis doxylamine/pyridoxine from Duchesnay to treat nausea and vomiting of pregnancy in women who do not respond to conservative management, including dietary and lifestyle changes. Duchesnay expects to launch the delayed-release tablet containing 10...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >